- Home
- RAMP vs SDGR Comparison
RAMP vs SDGR Comparison
Compare RAMP & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAMP
- SDGR
- Stock Information
- Founded
- RAMP 2018
- SDGR 1990
- Country
- RAMP United States
- SDGR United States
- Employees
- RAMP N/A
- SDGR N/A
- Industry
- RAMP EDP Services
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- RAMP Technology
- SDGR Health Care
- Exchange
- RAMP Nasdaq
- SDGR Nasdaq
- Market Cap
- RAMP 1.8B
- SDGR 1.7B
- IPO Year
- RAMP 1987
- SDGR 2020
- Fundamental
- Price
- RAMP $30.46
- SDGR $20.46
- Analyst Decision
- RAMP Buy
- SDGR Buy
- Analyst Count
- RAMP 6
- SDGR 5
- Target Price
- RAMP $40.67
- SDGR $32.80
- AVG Volume (30 Days)
- RAMP 651.1K
- SDGR 1.2M
- Earning Date
- RAMP 08-06-2025
- SDGR 07-30-2025
- Dividend Yield
- RAMP N/A
- SDGR N/A
- EPS Growth
- RAMP N/A
- SDGR N/A
- EPS
- RAMP N/A
- SDGR N/A
- Revenue
- RAMP $745,580,000.00
- SDGR $230,492,000.00
- Revenue This Year
- RAMP $10.01
- SDGR $24.44
- Revenue Next Year
- RAMP $9.39
- SDGR $22.17
- P/E Ratio
- RAMP N/A
- SDGR N/A
- Revenue Growth
- RAMP 13.03
- SDGR 22.29
- 52 Week Low
- RAMP $21.45
- SDGR $16.60
- 52 Week High
- RAMP $36.08
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- RAMP 46.00
- SDGR 37.57
- Support Level
- RAMP $29.80
- SDGR $20.90
- Resistance Level
- RAMP $31.89
- SDGR $21.62
- Average True Range (ATR)
- RAMP 0.69
- SDGR 1.37
- MACD
- RAMP -0.48
- SDGR -0.35
- Stochastic Oscillator
- RAMP 16.92
- SDGR 4.46
About RAMP LiveRamp Holdings Inc.
LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.